Literature DB >> 30315371

Transient neonatal diabetes mellitus and hypomethylation at additional imprinted loci: novel ZFP57 mutation and review on the literature.

Ameni Touati1,2, Javier Errea-Dorronsoro3, Sonia Nouri4,5, Yosra Halleb1,5, Arrate Pereda3, Nabiha Mahdhaoui4,5, Aida Ghith4,5, Ali Saad1,5, Guiomar Perez de Nanclares3, Dorra H'mida Ben Brahim6,7.   

Abstract

AIM: 6q24-related transient neonatal diabetes mellitus (6q24-TNDM) is a rare imprinting disorder characterized by uncontrolled hyperglycemia during the first 6 months of life. The molecular etiology of 6q24-TNDM is attributable to overexpression of the paternally inherited PLAGL1 and HYMAI genes located on the 6q24 locus. One of these major defects is maternal loss of methylation (LOM) at 6q24. In addition, approximately 50% of TNDM patients that present LOM at 6q24 can also display hypomethylation at additional imprinted loci (multilocus imprinting disturbances, MLID). Interestingly, the majority of these patients carry mutations in the ZFP57 gene, a transcription factor required for the adequate maintenance of methylation during early embryonic development.
METHODS: Methylation analysis of 6q24 and additional imprinted loci was carried out by MS-MLPA in a Tunisian male patient with clinical diagnosis of TNMD. For the same patient, mutation analysis of the ZFP57 gene was conducted by direct Sanger sequencing.
RESULTS: We report a novel nonsense mutation (c.373C > T; p.R125*; ENST00000376883.1) at the ZFP57 gene causing TNDM-MLID and describe detailed phenotype/epigenotype analysis of TNMD patients carrying ZFP57 mutations.
CONCLUSION: We provide additional support to the role of ZFP57 as a genetic determinant cause of MLID in patients with TNMD.

Entities:  

Keywords:  Multilocus imprinting disturbances (MLID); Transient neonatal diabetes mellitus; Tunisia; ZFP57 gene

Mesh:

Substances:

Year:  2018        PMID: 30315371     DOI: 10.1007/s00592-018-1239-3

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  5 in total

Review 1.  Genome Editing and Human Pluripotent Stem Cell Technologies for in vitro Monogenic Diabetes Modeling.

Authors:  Yosef Tsegaye Dabi; Sisay Teka Degechisa
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-11       Impact factor: 3.249

Review 2.  Monogenic diabetes: a gateway to precision medicine in diabetes.

Authors:  Haichen Zhang; Kevin Colclough; Anna L Gloyn; Toni I Pollin
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

3.  Genetic Spectrum of Neonatal Diabetes.

Authors:  M Kocova
Journal:  Balkan J Med Genet       Date:  2021-03-23       Impact factor: 0.519

Review 4.  Imprinting disorders in humans: a review.

Authors:  Merlin G Butler
Journal:  Curr Opin Pediatr       Date:  2020-12       Impact factor: 2.856

5.  The role of ZFP57 and additional KRAB-zinc finger proteins in the maintenance of human imprinted methylation and multi-locus imprinting disturbances.

Authors:  Ana Monteagudo-Sánchez; Jose Ramon Hernandez Mora; Carlos Simon; Adam Burton; Jair Tenorio; Pablo Lapunzina; Stephen Clark; Manel Esteller; Gavin Kelsey; Juan Pedro López-Siguero; Guiomar Perez de Nanclares; Maria-Elena Torres-Padilla; David Monk
Journal:  Nucleic Acids Res       Date:  2020-11-18       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.